Page last updated: 2024-09-03

icrf 193 and Colonic Neoplasms

icrf 193 has been researched along with Colonic Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Jain, CK; Majumder, HK; Roychoudhury, S	1

Other Studies

1 other study(ies) available for icrf 193 and Colonic Neoplasms

Article	Year
Selective killing of G2 decatenation checkpoint defective colon cancer cells by catalytic topoisomerase II inhibitor. Biochimica et biophysica acta, 2015, Volume: 1853, Issue:5 Topics: Biocatalysis; Cell Cycle Checkpoints; Cell Death; Cell Line, Tumor; Cell Survival; Chromosomes, Human; Colonic Neoplasms; Diketopiperazines; Etoposide; G2 Phase; HEK293 Cells; Humans; Mitosis; Mitotic Index; Piperazines; Topoisomerase II Inhibitors; Tumor Stem Cell Assay	2015

Article

Year

Selective killing of G2 decatenation checkpoint defective colon cancer cells by catalytic topoisomerase II inhibitor.

Biochimica et biophysica acta, 2015, Volume: 1853, Issue:5

Topics: Biocatalysis; Cell Cycle Checkpoints; Cell Death; Cell Line, Tumor; Cell Survival; Chromosomes, Human; Colonic Neoplasms; Diketopiperazines; Etoposide; G2 Phase; HEK293 Cells; Humans; Mitosis; Mitotic Index; Piperazines; Topoisomerase II Inhibitors; Tumor Stem Cell Assay

2015